Selective T Cell Costimulation Modulator [EPC]

113014 reported adverse events

Drugs of this class: ABATACEPT

These side effects are most commonly reported by patients taking drugs of the Selective T Cell Costimulation Modulator [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 35994
1 RHEUMATOID ARTHRITIS 19890
2 PAIN 17588
3 ARTHRALGIA 15342
4 JOINT SWELLING 14725
5 CONTRAINDICATED PRODUCT ADMINISTERED 12318
6 FATIGUE 11786
7 DRUG INTOLERANCE 11318
8 RASH 10432
9 ARTHROPATHY 9585
See all common reactions for Selective T Cell Costimulation Modulator [EPC]

Drugs of the Selective T Cell Costimulation Modulator [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 282 0.9246
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3537 0.8448
2 SWOLLEN JOINT COUNT INCREASED 1017 0.7976
3 RED BLOOD CELL SEDIMENTATION RATE 205 0.7885
4 RHEUMATOID FACTOR NEGATIVE 135 0.7849
5 PEMPHIGUS 6521 0.7764
6 RHEUMATOID FACTOR POSITIVE 2849 0.7677
7 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 204 0.7612
8 RHEUMATIC FEVER 1263 0.7438
9 LUPUS VULGARIS 173 0.6705
See all enriched reactions for Selective T Cell Costimulation Modulator [EPC]